From description to mechanism
In 2013 a group of researchers proposed that aging could be understood through nine hallmarks: measurable biological processes that appear with age, accelerate aging when experimentally worsened, and slow it when experimentally improved. In January 2023 the same group, led by Carlos López-Otín and including María Blasco, Linda Partridge, Manuel Serrano and Guido Kroemer, updated the framework in Cell to twelve hallmarks and noted that nearly 300,000 papers on aging had been published in the intervening decade, as many as in the whole previous century.
The twelve hallmarks
Primary hallmarks, the upstream sources of damage: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis (the ability to fold, repair and clear proteins) and disabled macroautophagy (the cell’s recycling system).
Antagonistic hallmarks, responses that protect in the short term and harm when chronic: deregulated nutrient sensing, mitochondrial dysfunction and cellular senescence.
Integrative hallmarks, where the damage shows at the level of tissues and the whole organism: stem cell exhaustion, altered intercellular communication, chronic inflammation and dysbiosis (an unhealthy shift in the gut microbiome).
Almost every one of these appears elsewhere on this site under a different name. Loss of proteostasis is the amyloid, tau and alpha-synuclein story. Disabled autophagy and mitochondrial dysfunction are the energy story. Chronic inflammation is the microglia story. The hallmarks framework is, in effect, a map of why brain diseases of aging are so interconnected.
What is being tested
The 2023 review summarises the intervention landscape: dietary restriction and drugs that act on the same nutrient-sensing pathways (rapamycin and related compounds, metformin); molecules that clear senescent cells, called senolytics; approaches to restore the cell’s NAD+ supply and mitochondrial function; partial epigenetic reprogramming, which has reversed some markers of age in animal cells and tissues; and interventions on inflammation and the microbiome. Most human evidence is early, and the review is careful to distinguish robust animal results from the far smaller body of human trial data.
Measurement is advancing alongside intervention. Epigenetic clocks, which estimate biological age from chemical marks on DNA, and blood biomarkers of organ-specific aging are making it possible to test whether an intervention changes the pace of aging within a trial’s timeframe rather than waiting decades for outcomes.
What this means for the brain
Age is the dominant risk factor for every neurodegenerative disease. If even some of the hallmarks can be slowed in people, the brain has the most to gain, because it is the organ least able to replace what it loses. That is why NeuroClearance treats longevity biology as part of its educational mission rather than a separate field. The honest state of the evidence today is that the only interventions with proven human benefit for brain aging are the unglamorous ones: blood pressure control, exercise, hearing and vision care, sleep, not smoking, and staying socially and mentally engaged.
How to read this page
This is general educational background drawn from the sources below. It is not medical advice, and it is not evidence that any NeuroClearance system works. Where a finding comes from animals or from a small human study, the text says so.